Underrepresentation of female subjects in BE study to register Generic [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-11 17:15 (1365 d 15:52 ago) – Posting: # 21254
Views: 4,293

Hi ElMaestro,

It's not a random flutter. Females actually fall back on bioequivalncy. Cmax at 75% and range was lower too. Pioneer product behaved similar way. So it's not random. You are right. The females also has higher variance.

I didn't understand your last statement. Can you kindly clarify?

❝ Yes, you can likely conduct the study in males. But why would you if you think the conclusion in males can be extrapolated


Cheers,

SKM

Complete thread:

UA Flag
Activity
 Admin contact
22,818 posts in 4,784 threads, 1,634 registered users;
31 visitors (1 registered, 30 guests [including 5 identified bots]).
Forum time: 09:07 CET (Europe/Vienna)

The greatest obstacle to discovery is not ignorance 
it is the illusion of knowledge.    Daniel J. Boorstin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5